Results 141 to 150 of about 76,581 (257)

A Case of Familial Mediterranean Fever Diagnosed After Oral Administration of a Gonadotropin-Releasing Hormone (GnRH) Antagonist. [PDF]

Cureus
Ueno H, Ohara R, Nakao S, Sasaki J, Satoh T.   +4 more
europepmc   +1 more source

Control of Gonadotropin Secretion in the Ovine Fetus: The Effects of a Specific Gonadotropin-Releasing Hormone Antagonist on Pulsatile Luteinizing Hormone Secretion* [PDF]

, 1987
Igor Matwijiw, Charles Faiman
openalex   +1 more source

Identification and Functional Characterization of a Novel SEMA3A Exon Deletion Variant in Kallmann Syndrome

Molecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
The study identified a novel SEMA3A exons 6–9 deletion variant in Kallmann syndrome that impairs GnRH neuronal migration and alters cell migration, gonad development, and synaptic pathways. The study expands mutation spectrum and offers mechanistic insights for clinical diagnosis of Kallmann syndrome.
Shaolian Zang, Shasha Zhou, Qingxu Liu, Xiaoqin Yin, Pin Li   +4 more
wiley   +1 more source

Gonadotropin-releasing hormone regulates transcription of the inhibin B co-receptor, TGFBR3L, via early growth response one. [PDF]

J Biol Chem
Lin YF, Buddle ERS, Schultz H, Zhou X, Mary Loka LO, Alonso CAI, Boehm U, Duggavathi R, Bernard DJ.   +8 more
europepmc   +2 more sources

Cost-effectiveness of dienogest compared to gonadotropin releasing hormone agonists for the management of endometriosis in Vietnam. [PDF]

Cost Eff Resour Alloc
Kieu MTT, Le MH, Nguyen CP.
europepmc   +1 more source

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

Nano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini, Gillian D. Mahumane, Pradeep Kumar, Yahya E. Choonara   +3 more
wiley   +1 more source

Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. [PDF]

J Clin Med Res
Wang JY, Zhang Y, Ding J.
europepmc   +1 more source

Supplementary Material for: Differential Gene Expression in Gonadotropin-Releasing Hormone Neurons of Male and Metestrous Female Mice

, 2017
Csaba Vastagh, Annie Rodolosse, Norbert Solymosi, Imre Farkas, Herbert Auer, Miklós Sárvári, Zsolt Liposits   +6 more
openalex   +1 more source

The effects of intramuscular or intravenous injections of gonadotropin releasing hormone at fixed-time artificial insemination on pregnancy rates of Bos indicus beef cows [PDF]

, 2014
Danilo Demeterco, Darren D Henry, Vitor R G Mercadante, G. C. Lamb, Francisco Romano Gaievski, Bruno Weiss, Gustavo Nascimento Turbay, Márcio Saporski Segui, Romildo Romualdo Weiss, Melina Andreia Formighieri Betiol, Luiz Ernandes Kozicki   +10 more
openalex   +1 more source

Upconverting Nanoparticle‐Loaded Microneedles for Near‐Infrared Responsive Delivery of Gonadotropins to Increase Success of In Vitro Fertilization

Small, Volume 22, Issue 1, 2 January 2026.
This paper describes the development of an upconverting particle‐integrated microneedle patch that can release the hormone leuprolide when the patch is exposed to near‐infrared light. This system represents proof‐of‐concept of a painless and automated method of delivering drugs at specific times when repeated time‐sensitive injections are required ...
Vivienne Tam, Rusvir Trana, Alfonso Nieto‐Arguello, Ore‐Oluwa Olasubulumi, Samuel Babity, Artiom Skripka, Fiorenzo Vetrone, Davide Brambilla, Marta Cerruti   +8 more
wiley   +1 more source